Thyroid hormones, iodine and iodides, and antithyroid drugs

[1]  S. Salah.  Neutropenia Associated with Methimazole Therapy in A 4.7-year Girl with Graves’ Disease. , 2020 .

[2]  M. Tomkins,et al.  Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis and agranulocytosis in a patient with Graves’ disease , 2019, Endocrinology, diabetes & metabolism case reports.

[3]  H. Moghimi,et al.  The efficacy and safety of topical 5% methimazole vs 4% hydroquinone in the treatment of melasma: A randomized controlled trial , 2020, Journal of cosmetic dermatology.

[4]  J. Hunter,et al.  Sinusitis, an under-reported adverse effect in children treated with radioactive iodine therapy and review of the current literature , 2019, Journal of pediatric endocrinology & metabolism : JPEM.

[5]  Weimin Cai,et al.  Association between genetic polymorphisms of SLCO1B1 and susceptibility to methimazole‐induced liver injury , 2019, Basic & clinical pharmacology & toxicology.

[6]  Weimin Cai,et al.  Mechanistic examination of methimazole-induced hepatotoxicity in patients with Grave’s disease: a metabolomic approach , 2019, Archives of Toxicology.

[7]  Pamela Chayavichitsilp,et al.  Methimazole-Induced Leukocytoclastic Vasculitis: A Case Report , 2019, Case Reports in Dermatology.

[8]  S.H. Wong.  Suppurative Lymphadenitis after Radioactive Iodine Therapy for Graves’ Disease: A Rare Complication? , 2019, European Thyroid Journal.

[9]  M. Al-khairalla,et al.  Levothyroxine-induced liver injury followed by complete recovery upon cessation of the drug: a case report , 2019, Journal of Medical Case Reports.

[10]  Saima Manzoor,et al.  73 - A Rare Case of Methimazole-Induced Concomitant Cholestasis and Severe Agranulocytosis That Recovered Rapidly With High Dose Filgrastim , 2019, Canadian Journal of Diabetes.

[11]  Weimin Cai,et al.  Association of HLA-C*03:02 with methimazole-induced liver injury in Graves' disease patients. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[12]  Cheng Xie,et al.  Liver injury induced by levothyroxine tablets in a patient with hypothyroidism , 2019, Chinese medical journal.

[13]  O. Olajide,et al.  Methimazole-Induced Pleural Effusion in the Setting of Graves' Disease , 2019, Case reports in endocrinology.

[14]  Natasha Singh,et al.  Initiation of levothyroxine in a patient with hypothyroidism inducing adrenal crisis requiring VA ECMO: a tale of preventable disaster , 2019, BMJ Case Reports.

[15]  Tulsi Sharma,et al.  Type II polyglandular autoimmune syndrome: a case of Addison’s disease precipitated by use of levothyroxine , 2019, BMJ Case Reports.

[16]  M. Dias,et al.  Propylthiouracil-induced agranulocytosis as a rare complication of antithyroid drugs in a patient with Graves' disease. , 2019, Revista da Associacao Medica Brasileira.

[17]  Cheng-ping Hu,et al.  Propylthiouracil-induced organizing pneumonia , 2019, Medicine.

[18]  Chengwu Shen,et al.  Liver dysfunction induced by Levothyroxine Sodium Tablets (Euthyrox®) in a hypothyroid patient with Hashimoto's thyroiditis: case report and literature review. , 2019, Endocrine journal.

[19]  Dyah Purnamasari,et al.  Gastroschisis Following Treatment with High-Dose Methimazole in Pregnancy: A Case Report , 2019, Drug Safety - Case Reports.

[20]  Celeste Ong-Ramos,et al.  Methimazole-Induced Aplastic Anemia with Concomitant Hepatitis in a Young Filipina with Graves’ Disease , 2019, Journal of the ASEAN Federation of Endocrine Societies.

[21]  F. Azizi,et al.  Treatment of Toxic Multinodular Goiter: Comparison of Radioiodine and Long-Term Methimazole Treatment. , 2019, Thyroid : official journal of the American Thyroid Association.

[22]  F. Azizi,et al.  Long-term Methimazole Therapy in Juvenile Graves’ Disease: A Randomized Trial , 2019, Pediatrics.

[23]  N. Uppal,et al.  Systemic p-ANCA vasculitis with fatal outcome, arising in the setting of methimazole use , 2019, Clinical nephrology. Case studies.

[24]  B. Källén.  Maternal Use of Drugs for Thyroid Disease and Infant Congenital Malformations , 2019, Maternal Drug Use and Infant Congenital Malformations.